Abstract:Abstract Background Breast cancer is the most prevalent and among the most deadly cancers in females. Patients with breast cancer have highly variable survival lengths, indicating a need to identify prognostic biomarkers for personalized diagnosis and treatment. With the development of new technologies such as next-generation sequencing, multi-omics information are becoming available for a more thorough evaluation of a patient’s condition. In this study, we aim to improve breast cancer overall survival prediction by integrating multi-omics data (e.g., gene expression, DNA methylation, miRNA expression, and copy number variations (CNVs)). Methods Motivated by multi-view learning, we propose a novel strategy to integrate multi-omics data for breast cancer survival prediction by applying complementary and consensus principles. The complementary principle assumes each -omics data contains modality-unique information. To preserve such information, we develop a concatenation autoencoder (ConcatAE) that concatenates the hidden features learned from each modality for integration. The consensus principle assumes that the disagreements among modalities upper bound the model errors. To get rid of the noises or discrepancies among modalities, we develop a cross-modality autoencoder (CrossAE) to maximize the agreement among modalities to achieve a modality-invariant representation. We first validate the effectiveness of our proposed models on the MNIST simulated data. We then apply these models to the TCCA breast cancer multi-omics data for overall survival prediction. Results For breast cancer overall survival prediction, the integration of DNA methylation and miRNA expression achieves the best overall performance of 0.641 ± 0.031 with ConcatAE, and 0.63 ± 0.081 with CrossAE. Both strategies outperform baseline single-modality models using only DNA methylation (0.583 ± 0.058) or miRNA expression (0.616 ± 0.057). Conclusions In conclusion, we achieve improved overall survival prediction performance by utilizing either the complementary or consensus information among multi-omics data. The proposed ConcatAE and CrossAE models can inspire future deep representation-based multi-omics integration techniques. We believe these novel multi-omics integration models can benefit the personalized diagnosis and treatment of breast cancer patients.

Cancer survival prediction by learning comprehensive deep feature representation for multiple types of genetic data

Learning Comprehensive Multimodal Representation for Cancer Survival Prediction

Cancer Survival Prediction by Multimodal Disentangled Representation Learning.

Multimodal Survival Ensemble Network: Integrating Genomic and Histopathological Insights for Enhanced Cancer Prognosis.

A Deep Learning-Based Multi-Model Ensemble Method for Cancer Prediction.

Pancancer survival prediction using a deep learning architecture with multimodal representation and integration

Long-term cancer survival prediction using multimodal deep learning

Deep learning-based survival prediction for multiple cancer types using histopathology images

Survival Prediction in Lung Cancer through Multi-Modal Representation Learning

Deep learning based feature-level integration of multi-omics data for breast cancer patients survival analysis

Integrating multi-omics data through deep learning for accurate cancer prognosis prediction

A Multi-Modal Graph-Based Semi-Supervised Pipeline for Predicting Cancer Survival

A Cancer Survival Prediction Method Based on Graph Convolutional Network

A Novel Pathological Images and Genomic Data Fusion Framework for Breast Cancer Survival Prediction.

Multiomics-Based Feature Extraction and Selection for the Prediction of Lung Cancer Survival

Integrating Biological Knowledge with Gene Expression Profiles for Survival Prediction of Cancer

Strategies to integrate multi-omics data for patient survival prediction

Integrating multi-omics data by learning modality invariant representations for improved prediction of overall survival of cancer

Diagnosis-Guided Multi-modal Feature Selection for Prognosis Prediction of Lung Squamous Cell Carcinoma

Multimodal Data Integration Using Deep Learning Predicts Overall Survival of Patients with Glioma

Two-Stage Prediction of Comorbid Cancer Patient Survivability Based on Improved Infinite Feature Selection.